Axl Monoclonal Antibody

The protein encoded by this gene is a member of the Tyro3-Axl-Mer (TAM) receptor tyrosine kinase subfamily. The encoded protein possesses an extracellular domain which is composed of two immunoglobulin-like motifs at the N-terminal, followed by two fibronectin type-III motifs. It transduces signals from the extracellular matrix into the cytoplasm by binding to the vitamin K-dependent protein growth arrest-specific 6 (Gas6). This gene may be involved in several cellular functions including growth, migration, aggregation and anti-inflammation in multiple cell types. Alternative splicing results in multiple transcript variants of this gene.

Introducing the AXL Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of molecular research and diagnostics. This meticulously crafted antibody is specifically engineered to target and bind to the AXL receptor tyrosine kinase, a crucial protein involved in various cellular processes.

The AXL Monoclonal Antibody boasts exceptional specificity and affinity, ensuring precise and reliable detection of AXL expression in a wide range of biological samples. Its superior performance is attributed to the utilization of state-of-the-art hybridoma technology, resulting in a highly purified and standardized antibody with minimal batch-to-batch variation.

With its unrivaled sensitivity, the AXL Monoclonal Antibody enables researchers and clinicians to delve into the intricate mechanisms underlying AXL signaling pathways, facilitating a deeper understanding of its role in disease progression and therapeutic response. This invaluable tool empowers scientists to unravel the complexities of cancer, immunology, and other pathophysiological conditions, paving the way for novel therapeutic interventions and personalized medicine.

The AXL Monoclonal Antibody is meticulously validated through rigorous quality control measures, ensuring its exceptional performance and reproducibility. Its versatility extends to various applications, including immunohistochemistry, western blotting, flow cytometry, and immunofluorescence, enabling comprehensive analysis across diverse experimental platforms.

Furthermore, this antibody is meticulously manufactured in compliance with stringent regulatory guidelines, guaranteeing its safety, reliability, and consistency. Each batch is meticulously characterized, providing researchers with the utmost confidence in their experimental results.

In summary, the AXL Monoclonal Antibody represents a breakthrough in molecular research, offering unparalleled specificity, sensitivity, and reproducibility. With its exceptional performance and versatility, this antibody serves as an indispensable tool for elucidating the intricate mechanisms underlying AXL signaling pathways, ultimately driving advancements in diagnostics, therapeutics, and personalized medicine.